Skip to content

Price / sales at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
1.6×+0.1×
Revvity logo
RevvityRVTY
3.4×-1.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.9×+0.2×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
5.1×+0.8×
IQVIA logo
IQVIAIQV
1.7×-0.3×
TEC
Bio-TechneTECH
6.8×-0.9×

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Calculated from Charles River Laboratories’s reported figures.

Based on the most recent quarter.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's price / sales?
Charles River Laboratories (CRL) reported price / sales of 2.1× in Q1 2026.
How has Charles River Laboratories's price / sales changed year-over-year?
Charles River Laboratories's price / sales increased by 10.2% year-over-year, from 1.9× to 2.1×.
What is the long-term trend for Charles River Laboratories's price / sales?
Over 5 years (2020 to 2025), Charles River Laboratories's price / sales has grown at a -10.7% compound annual growth rate (CAGR), from 4.3× to 2.4×.
What does price / sales mean?
How many dollars investors pay for each dollar of the company's annual sales.
How do you interpret price / sales?
Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
How does price / sales compare across companies?
Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.